AZUSA, Calif.--(BUSINESS WIRE)--Viral Genetics (Pink Sheets: VRAL) subsidiary V-Clip Pharmaceuticals has expanded the existing Exclusive License Agreement with the University of Colorado by obtaining two Exclusive Option Agreements to acquire rights for treatment and detection of several forms of cancer including lung, breast, leukemia, and others, multiple sclerosis, diabetes, rheumatoid arthritis, malaria and several other diseases using technology developed by Professor M. Karen Newell, PhD, who is the Clement and Margaret Merkert-endowed Professor of Biology at the University of Colorado, Colorado Springs. The existing Exclusive License Agreement was previously restricted to HIV/AIDS, Herpes, and Hepatitis C.
